Abstract:Both neuroimaging and genomics datasets are often gathered for the detection of neurodegenerative diseases. Huge dimensionalities of neuroimaging data as well as omics data pose tremendous challenge for methods integrating multiple modalities. There are few existing solutions that can combine both multi-modal imaging and multi-omics datasets to derive neurological insights. We propose a deep neural network architecture that combines both structural and functional connectome data with multi-omics data for disease classification. A graph convolution layer is used to model functional magnetic resonance imaging (fMRI) and diffusion tensor imaging (DTI) data simultaneously to learn compact representations of the connectome. A separate set of graph convolution layers are then used to model multi-omics datasets, expressed in the form of population graphs, and combine them with latent representations of the connectome. An attention mechanism is used to fuse these outputs and provide insights on which omics data contributed most to the model's classification decision. We demonstrate our methods for Parkinson's disease (PD) classification by using datasets from the Parkinson's Progression Markers Initiative (PPMI). PD has been shown to be associated with changes in the human connectome and it is also known to be influenced by genetic factors. We combine DTI and fMRI data with multi-omics data from RNA Expression, Single Nucleotide Polymorphism (SNP), DNA Methylation and non-coding RNA experiments. A Matthew Correlation Coefficient of greater than 0.8 over many combinations of multi-modal imaging data and multi-omics data was achieved with our proposed architecture. To address the paucity of paired multi-modal imaging data and the problem of imbalanced data in the PPMI dataset, we compared the use of oversampling against using CycleGAN on structural and functional connectomes to generate missing imaging modalities. Furthermore, we performed ablation studies that offer insights into the importance of each imaging and omics modality for the prediction of PD. Analysis of the generated attention matrices revealed that DNA Methylation and SNP data were the most important omics modalities out of all the omics datasets considered. Our work motivates further research into imaging genetics and the creation of more multi-modal imaging and multi-omics datasets to study PD and other complex neurodegenerative diseases.

Multi-Omic Graph Diagnosis (MOGDx) : A data integration tool to perform classification tasks for heterogeneous diseases

MOGONET integrates multi-omics data using graph convolutional networks allowing patient classification and biomarker identification

Integration of multi-omics data using adaptive graph learning and attention mechanism for patient classification and biomarker identification

MOHGCN: A Trustworthy Multi-Omics Data Integration Framework Based on Specificity-Aware Heterogeneous Graph Convolutional Neural Networks for Disease Diagnosis

TMODINET: A trustworthy multi-omics dynamic learning integration network for cancer diagnostic

LASSO-MOGAT: A Multi-Omics Graph Attention Framework for Cancer Classification

Comparative Analysis of Multi-Omics Integration Using Advanced Graph Neural Networks for Cancer Classification

MODIG: Integrating Multi-Omics and Multi-Dimensional Gene Network for Cancer Driver Gene Identification Based on Graph Attention Network Model.

MoGCN: A Multi-Omics Integration Method Based on Graph Convolutional Network for Cancer Subtype Analysis

MOSDNET: A multi-omics classification framework using simplified multi-view deep discriminant representation learning and dynamic edge GCN with multi-task learning

How to build personalized multi-omics comorbidity profiles

GREMI: An Explainable Multi-Omics Integration Framework for Enhanced Disease Prediction and Module Identification

A Multi-Omics Integration Framework Using Graph Attention Networks for Cancer Subtype Prediction

DM-MOGA: a multi-objective optimization genetic algorithm for identifying disease modules of non-small cell lung cancer

Heterogeneous graph attention network improves cancer multiomics integration

Multi-omics integration with weighted affinity and self-diffusion applied for cancer subtypes identification

Multi-Omics Analysis for Improved Diagnosis, Prognosis, and Drug Response Prediction in Digestive System Tumors

Combining Neuroimaging and Omics Datasets for Disease Classification Using Graph Neural Networks

A Novel Tool for Multi-Omics Network Integration and Visualization: A Study of Glioma Heterogeneity

Identification of Multidimensional Regulatory Modules Through Multi-Graph Matching with Network Constraints.

Predicting Drug Response Based on Multi-Omics Fusion and Graph Convolution